News and Trends 22 Jan 2020 FDA Greenlights First Treatment for Rare Autoimmune Eye Disease An antibody drug developed by the Irish biopharma Horizon Therapeutics has been approved by the FDA for the treatment of adults with the rare autoimmune condition thyroid eye disease. The approval of the drug came ahead of schedule, with the decision originally expected in March. The drug, a monoclonal antibody, is branded as Tepezza. Thyroid […] January 22, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jan 2020 Off-The-Shelf Lung Cancer Vaccine Clinical Trial Gets €20M Boost The French-Belgian company PDC*Line Pharma has raised a €20M Series B round to fund an ongoing phase I/II trial of its off-the-shelf therapeutic vaccine for lung cancer. The total €20M consists of €13.9M in equity investments and €6.1M in loans and subsidies from the Walloon Region of Belgium. PDC*Line’s current investors took part in the […] January 22, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jan 2020 T-Cell Discovery Could Herald Universal Cancer Immunotherapy An international research team has found a new type of T-cell that could lead to cell immunotherapies able to treat cancers beyond the reach of current CAR T-cell therapies. Market-approved CAR T-cell therapies including Yescarta and Kymriah have revolutionized cancer treatment by modifying immune T-cells to hunt down cancer cells. However, these treatments are only […] January 21, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 21 Jan 2020 How Biotech Startups Can Have a Stronger Position When Scaling Up Scaling up the manufacturing process can be a daunting task for any biotech startup. Evelina Vågesjö, CEO of Swedish gene therapy biotech Ilya Pharma, and Jesper Hedberg, Director of the Testa Center facility, explained how testing at innovation facilities such as incubators and biotech accelerators can help avoid big pitfalls in the scaling process later […] January 21, 2020 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jan 2020 German Biotech Raises €11M to Regenerate Liver Damage Biotech company HepaRegeniX has raised a Series B round that will allow its first candidate drug for liver disease to enter clinical trials later this year. Based in Tübingen, Germany, HepaRegenix was founded in 2017 with a €9M Series A round. The same investors are now taking part in a Series B round […] January 21, 2020 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jan 2020 Medical Gel Prepares to Enter Clinical Trials for Replacing Corneal Transplants An international collaboration involving researchers in Europe, Asia, and North America has begun preparations for testing in humans a therapeutic gel that could replace the need for corneal transplants for the treatment of blindness. Corneal transplants are the most common treatment for blindness caused by corneal injury. However, donor shortages and high costs make it […] January 20, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Jan 2020 How Much Salary Can You Expect in a Biotech Job? If you’re thinking of taking a job in biotech, you’re probably wondering how much you’ll be paid. Here’s what you can expect depending on how high in the ladder your new position is. Salary is undoubtedly an important factor when searching for a new job position, so it’s important to know what you can expect. […] January 20, 2020 - 7 minutesmins - By Karen O’Hanlon Cohrt Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jan 2020 DNA Data Storage Project Receives €20.7M from US Intelligence Agency A DNA data storage project, involving French biotech DNA Script, has been awarded a contract worth up to €20.7M from the US Intelligence Advanced Research Projects Activity agency to develop a prototype instrument able to store and retrieve 1 terabyte of information in 24 hours. The Molecular Encoding Consortium, led by Robert Nicol at the Broad […] January 18, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jan 2020 International Collaboration on Brink of Resurrecting Northern White Rhinos An international collaboration called BioRescue has taken a step forward in bringing back the Northern White Rhino with the creation of three embryos, which it hopes to bring to term in a surrogate in the coming months. The BioRescue team, including researchers based at the Leibniz Institute for Zoo and Wildlife Research, Germany, extracted egg […] January 17, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 17 Jan 2020 This Biotech Is Developing a Pill to Rival Antibiotics in Vaginal Infections Gedea Biotech is nestled in the historic city of Lund, Sweden. The company is developing a pill that could tackle recurrent bacterial vaginosis infections without harming the vaginal microbiome like current antibiotics do. Mission: To develop a pill that can clear bacterial vaginosis by restoring normal acidity levels in the vagina, which helps good bacteria […] January 17, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jan 2020 Biotech Investment Firm Jeito Capital Launches with €200M Fund The French investment firm Jeito Capital has launched this week with a €200M fund that will support up to 15 drug-development start-ups with a focus on European companies. Jeito Capital is the brainchild of Rafaèle Tordjman, whose background in medicine and research as well as investment in life sciences led her to setting up the […] January 16, 2020 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jan 2020 BioNTech Expands Cancer Portfolio With US Biotech Acquisition German cancer specialist BioNTech will acquire US T-cell therapy biotech Neon Therapeutics in a deal worth €60M, both to expand its cancer therapy pipeline and establish a US base. The deal is expected to complete in the second half of 2020, after which Neon will operate as a subsidiary of BioNTech. BioNTech has arguably scooped […] January 16, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email